Warner Chilcott Plc

Warner Chilcott Plc WCRX

This security is delisted

Dividend Summary


The previous Warner Chilcott Plc dividend was 25c and it went ex almost 11 years ago and it was paid almost 11 years ago.
There are typically 2 dividends per year (excluding specials), and the dividend cover is approximately 7.0.

Latest Dividends
Summary Previous dividend Next dividend
Status Paid
Type Final
Per share 25c
Declaration date 07 May 2013 (Tue)
Ex-div date 29 May 2013 (Wed)
Pay date 14 Jun 2013 (Fri)

Enter the number of Warner Chilcott Plc shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
We have not made any dividend predictions for Warner Chilcott Plc
Dividend Yield Today
0.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Warner Chilcott Plc
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Paid Final 07 May 2013 29 May 2013 14 Jun 2013 USD 25c
Paid Interim 06 Nov 2012 30 Nov 2012 14 Dec 2012 USD 25c
Paid Special 31 Aug 2012 10 Sep 2012 USD 400c
Paid Special 30 Aug 2010 08 Sep 2010 USD 850c
Paid Final 31 Dec 2009 31 Dec 2009 USD 0c
Paid Final 31 Dec 2008 31 Dec 2008 USD 0c
Paid Final 31 Dec 2007 31 Dec 2007 USD 0c
Paid Final 31 Dec 2006 31 Dec 2006 USD 0c
Year Amount Change
2006 0.0c
2007 0.0c
0%
2008 0.0c
0%
2009 0.0c
0%
2010 0.0c
0%
2011 0.0c
0%
2012 0.0c
0%
2013 50.0c
100%

Warner Chilcott Plc Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
0.0%
Optimized Yield
Sign Up Required
52 Week High
0.0% on  
52 Week Low
0.0% on  
Next Ex-Div-Date Countdown
Sign Up Required

About Warner Chilcott Plc

October 1, 2013: Actavis (NYSE: ACT) announced the acquisition of Warner Chilcott plc

Warner Chilcott is a global specialty pharmaceutical company currently focused on the gastroenterology, women's healthcare, dermatology and urology segments of the U.S. and Western European pharmaceuticals markets. Since being spun out of Warner-Lambert in 1996, Warner Chilcott has evolved, through a series of acquisitions and divestitures, from a small seller of undifferentiated products to a fully integrated pharmaceutical company with a broad portfolio of leading branded products. The acquisition of The Procter & Gamble Company's global branded pharmaceuticals business on October 30, 2009 transformed Warner Chilcott into a global pharmaceuticals company with significant scale and geographic reach. Today, Warner Chilcott has an expanded sales force and infrastructure to better promote products in the U.S., major Western European and other markets, increased diversity of revenue sources, enhanced product development capabilities and a deeper product development pipeline.

Headquartered in Dublin, Ireland, Warner Chilcott has employees in 12 countries in North America and Western Europe. The Company's manufacturing facilities are located in Puerto Rico, Northern Ireland and Germany. Warner Chilcott is listed on the Nasdaq Stock Exchange and trades under the symbol WCRX.

Warner Chilcott paid their First Semi-Annual Cash Dividend December 14, 2012

Sector
Pharmaceuticals & Biotechnology
Country
United States
Share Price
$22.93 (closing price on 30 Sep 2013)
Shares in Issue
250 million
Market Cap
$5.7bn
Dividend Cover
How many times is the dividend covered by company income. A cover of 1 means all income is paid out in dividends
7.0
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
1
Market Indices
none
Financial Calendar URL
Sign Up Required
Home Page URL
https://www.allergan.com/news/news/warner-chilcott-is-now-actavis
Investor Relations URL
Sign Up Required